Maureen Laffoon

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design”.

Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design

Lara D. Veeken(2021)10.1093/rheumatology/keab075

N/A

0DataRank · unranked

20 citations

Shiyao Gao, Maureen Laffoon, Stephen R. Wisniewski, Yuqing Zhang, Virginia Steen +3 more

A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials

Lara D. Veeken(2022)10.1093/rheumatology/keac501

N/A

0DataRank · unranked

7 citations

Thomas A. Medsger, Shiyao Gao, Maureen Laffoon, Suiyuan Huang, Stephen R. Wisniewski +5 more

Distinct Scleroderma Autoantibody Profiles Stratify Patients for Cancer Risk at Scleroderma Onset and During the Disease Course

Arthritis & Rheumatology(2023)10.1002/art.42663

N/A

0DataRank · unranked

14 citations

Adrianne Woods, Laura Gutierrez‐Alamillo, Maureen Laffoon, Fredrick M. Wigley, Laura K. Hummers +6 more

Effects of Audio‐Guided Imagery on Raynaud Phenomenon in Connective Tissue Disease

ACR Open Rheumatology(2025)10.1002/acr2.70074

N/A

0DataRank · unranked

1 citations

Veena Katikineni, Yongseok Park, Leigh A. Freno, Maureen Laffoon, Lee Reichbaum +3 more